Calcipotriene/betamethasone dipropionate aerosol foam: Phase III data

The double-blind, placebo-controlled, U.S. Phase III PSO-FAST trial in 426 patients with psoriasis vulgaris showed that Enstilar improved itch in 37% of patients after 3 days and in 84% of patients by...